Multi-functional characteristics of the Pseudomonas aeruginosa type III needle-tip protein, PcrV; comparison to orthologs in other Gram-negative bacteria

Frontiers in Microbiology

Volumn 2, Issue JULY, 2011, Pages

  Sato, Hiromi ^a   Frank, Dara W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

LcrV; Needle tip proteins; PcrV; Protective antigen; Pseudomonas aeruginosa; Type iii secretion; Yersinia

Indexed keywords

AEROMONAS; BACTERIA (MICROORGANISMS); BORDETELLA; BURKHOLDERIA; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA; SALMONELLA; SHIGELLA; VIBRIO; YERSINIA;

EID: 84857946668     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00142     Document Type: Article

References (181)

1. Abramov, V. M., Khlebnikov, V. S., Vasiliev, A. M., Kosarev, I. V., Vasilenko, R. N., Kulikova, N. L., Khodyakova, A. V., Evstigneev, V. I., Uversky, V. N., Motin, V. L., Smirnov, G. B., and Brubaker, R. R. (2007). Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor. J. Proteome Res. 6, 2222-2231.
2. Agrain, C., Callebaut, I., Journet, L., Sorg, I., Paroz, C., Mota, L. J., and Cornelis, G. R. (2005). Characterization of a type III secretion substrate specificity switch (T3S4) domain in YscP from Yersinia enterocolitica. Mol. Microbiol. 56, 54-67.
3. Aili, M., Isaksson, E. L., Carlsson, S. E., Wolf-Watz, H., Rosqvist, R., and Francis, M. S. (2008). Regulation of Yersinia Yop-effector delivery by translocated YopE. Int. J. Med. Microbiol. 298, 183-192.
4. Akeda, Y., and Galan, J. E. (2005). Chap-erone release and unfolding of substrates in type III secretion. Nature 437,911-915.
5. Anderson, D. M., Ciletti, N. A., Lee-Lewis, H., Elli, D., Segal, J., DeBord, K. L., Overheim, K. A., Tretiakova, M., Brubaker, R. R., and Schneewind, O. (2009). Pneumonic plague patho-genesis and immunity in Brown Norway rats. Am. J. Pathol. 174, 910-921.
6. Anderson, G. W. Jr., Leary, S. E., Williamson, E. D., Titball, R. W., Welkos, S. L., Worsham, P. L., and Friedlander, A. M. (1996). Recombi-nant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect. Immun. 64, 4580-4585.
7. Arnoldo, A., Curak, J., Kittanakom, S., Chevelev, I., Lee, V. T., Sahebol-Amri, M., Koscik, B., Ljuma, L., Roy, P. J., Bedalov, A., Giaever, G., Nislow, C., Merrill, A. R., Lory, S., and Stagljar, I. (2008). Identification of small molecule inhibitors of Pseudomonas aeruginosa exoen-zyme S using a yeast phenotypic screen. PLoS. Genet. 4, e1000005. doi: 10.1371/journal.pgen.1000005
8. Baer, M., Sawa, T., Flynn, P., Luehrsen, K., Martinez, D., Wiener-Kronish, J. P., Yarranton, G., and Bebbington, C. (2009). An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity. Infect. Immun. 77, 1083-1090.
9. Bahrani, E K., Sansonetti, P. J., and Parsot, C. (1997). Secretion of Ipa proteins by Shigella flexneri: inducer molecules and kinetics of activation. Infect. Immun. 65, 4005-4010.
10. Baron, C. (2010). Antivirulence drugs to target bacterial secretion systems. Curr. Opin. Microbiol. 13, 100-105.
11. Bergman, T., Hakansson, S., Forsberg, A., Norlander, L., Macellaro, A., Backman, A., Bolin, I., and Wolf-Watz, H. (1991). Analysis of the V antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV.J. Bacteriol. 173, 1607-1616.
12. Betts-Hampikian, H. J., and Fields, K. A. (2010). The chlamydial type III secretion mechanism: revealing cracks in a tough nut. Front. Microbiol. 2:114. doi: 10.3389/fmicb.2010.00114
13. Bhattacharya, D., Mecsas, J., and Hu, L. T. (2010). Development of avaccinia virus based reservoir-targeted vaccine against Yersinia pestis. Vaccine 28, 7683-7689.
14. Birtalan, S. C., Phillips, R. M., and Ghosh, P. (2002). Three-dimensional secretion signals in chaperone-effector complexes of bacterial pathogens. Mol. Cell 9, 971-980.
15. Blocker, A., Gounon, P., Larquet, E., Niebuhr, K., Cabiaux, V., Parsot, C., and Sansonetti, P. (1999). The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes. J. Cell Biol. 147, 683-693.
16. Blocker, A. J., Deane, J. E., Veenendaal, A. K., Roversi, P., Hodgkinson, J. L., Johnson, S., and Lea, S. M. (2008). What's the point of the type III secretion system needle? Proc. Natl. Acad. Sci. U.S.A. 105,6507-6513.
17. Bordi, C., Lamy, M. C., Ventre, I., Termine, E., Hachani, A., Fillet, S., Roche, B., Bleves, S., Mejean, V., Lazdunski, A., and Filloux, A. (2010). Regulatory RNAs and the HptB/RetS signalling pathways fine-tune Pseudomonas aeruginosa pathogenesis. Mol. Microbiol. 76, 1427-1443.
18. Botteaux, A., Sory, M. P., Biskri, L., Parsot, C., and Allaoui, A. (2009). MxiC is secreted by and controls the substrate specificity of the Shigella flexneri type III secretion apparatus. Mol. Microbiol. 71, 449-460.
19. Boyd, A. P., Lambermont, I., and Cornelis, G. R. (2000). Competition between the Yops of Yersinia enterocolitica for delivery into eukary-otic cells: role of the SycE chaperone binding domain of YopE. J. Bacteriol. 182,4811-4821.
20. Broms, J. E., Sundin, C., Francis, M. S., and Forsberg, A. (2003). Comparative analysis of type III effector translocation by Yersinia pseudotuberculosis expressing native LcrV or PcrV from Pseudomonas aeruginosa. J. Infect. Dis. 188, 239-249.
21. Broz, P., Mueller, C. A., Muller, S. A., Philippsen, A., Sorg, I., Engel, A., and Cornelis, G. R. (2007). Function and molecular architecture of the Yersinia injectisome tip complex. Mol. Microbiol. 65, 1311-1320.
22. Brubaker, R. R. (2003). Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect. Immun. 71, 3673-3681.
23. Brutinel, E. D., Vakulskas, C. A., and Yahr, T. L. (2009). Functional domains of ExsA, the transcriptional activator of the Pseudomonas aeruginosa type III secretion system. J. Bacteriol. 191,3811-3821.
24. Brutinel, E. D., and Yahr, T. L. (2008). Control of gene expression by type III secretory activity. Curr. Opin. Microbiol. 11, 128-133.
25. Bumann, D., Behre, C., Behre, K., Herz, S., Gewecke, B., Gessner, J. E., von Specht, B. U., and Baumann, U. (2010). Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers. Vaccine 28, 707-713.
26. Burrows, T. W., and Bacon, G. A. (1956). The basis of virulence in Pas-teurella pestis: an antigen determining virulence. Br. J. Exp. Pathol. 37, 481-493.
27. Caroline, G., Eric, F., Bohn, Y. S., Sylvie, E., and Attree, I. (2008). Oligomer-ization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis. J. Biol. Chem. 283, 23940-23949.
28. Carter, P. B., Zahorchak, R. J., and Brubaker, R. R. (1980). Plague virulence antigens from Yersinia enterocolitica. Infect. Immun. 28, 638-640.
29. Chatterjee, S., Zhong, D., Nordhues, B. A., Battaile, K. P., Lovell, S., and De Guzman, R. N. (2011). The crystal structures of the Salmonella type III secretion system tip protein SipD in complex with deoxycholate and chenodeoxycholate. Protein Sci. 20, 75-86.
30. Chattopadhyay, A., Park, S., Delmas, G., Suresh, R., Senina, S., Perlin, D. S., and Rose, J. K. (2008). Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4(cells are required at the time of challenge for optimal protection. Vaccine 26, 6329-6337.
31. Cisz, M., Lee, P. C., and Rietsch, A. (2008). ExoS controls the cell contact-mediated switch to effector secretion in Pseudomonas aeruginosa. J. Bacteriol. 190,2726-2738.
32. Cornelis, G. R. (2002). The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell Biol. 3, 742-752.
33. Cornelis, G. R. (2006). The type III secretion injectisome. Nat. Rev. Microbiol. 4, 811-825.
34. Cornelius, C. A., Quenee, L. E., Overheim, K. A., Koster, F., Brasel, T. L., Elli, D., Ciletti, N. A., and Schneewind, O. (2008). Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague. Infect. Immun. 76, 5588-5597.
35. Crepin, V E, Shaw, R., Abe, C. M., Knut-ton, S., and Frankel, G. (2005). Polarity of enteropathogenic Escherichia coli EspA filament assembly and protein secretion. J. Bacteriol. 187, 2881-2889.
36. Daniell, S. J., Takahashi, N., Wilson, R., Friedberg, D., Rosenshine, I., Booy, F. P., Shaw, R. K., Knutton, S., Frankel, G., and Aizawa, S. (2001). The filamentous type III secretion translo-con of enteropathogenic Escherichia coli. Cell. Microbiol. 3, 865-871.
37. Dasgupta, N., Lykken, G. L., Wolfgang, M. C., and Yahr, T. L. (2004). A novel anti-anti-activator mechanism regulates expression of the Pseudomonas aeruginosa type III secretion system. Mol. Microbiol. 53,297-308.
38. Davis, A. J., Diaz, D. A., and Mecsas, J. (2010). A dominant-negative needle mutant blocks type III secretion of early but not late substrates in Yersinia. Mol. Microbiol. 76, 236-259.
39. Davis, A. J., and Mecsas, J. (2007).Mutations in the Yersinia pseudotuberculosis type III secretion system needle protein, YscF, that specifically abrogate effector translocation into host cells.J. Bacteriol. 189,83-97.
40. Deane, J. E., Roversi, P., Cordes, F. S., Johnson, S., Kenjale, R., Daniell, S., Booy, F., Picking, W D., Picking, W L., Blocker, A. J., and Lea, S. M. (2006). Molecular model of a type III secretion system needle: Implications for host-cell sensing. Proc. Natl. Acad. Sci. U.S.A. 103, 12529-12533.
41. DeBord, K. L., Anderson, D. M., Marketon, M. M., Overheim, K. A., Depaolo, R. W., Ciletti, N. A., Jabri, B., and Schneewind, O. (2006). Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect. Immun. 74, 4910-4914.
42. DeBord, K. L., Lee, V. T., and Schneewind, O. (2001). Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica. J. Bacteriol. 183,4588-4598.
43. Depaolo, R. W., Tang, F., Kim, I., Han, M., Levin, N., Ciletti, N., Lin, A., Anderson, D., Schneewind, O., and Jabri, B. (2008). Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host. Microbe 4, 350-361.
44. Derewenda, U., Mateja, A., Devedjiev, Y., Routzahn, K. M., Evdokimov, A. G., Derewenda, Z. S., and Waugh, D. S. (2004). The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague. Structure 12, 301-306.
45. Desin, T. S., Mickael, C. S., Lam, P. K., Potter, A. A., and Koster, W. (2010). Protection of epithelial cells from Salmonella enterica serovar Enteri-tidis invasion by antibodies against the SPI-1 type III secretion system. Can. J. Microbiol. 56, 522-526.
46. Dickenson, N. E., Zhang, L., Epler, C. R., Adam, P. R., Picking, W. L., and Picking, W. D. (2011). Conforma-tional changes in IpaD from Shigella flexneri upon binding bile salts provide insight into the second step of type III secretion. Biochemistry 50, 172-180.
47. Druar, C., Yu, F., Barnes, J. L., Oki-naka, R. T., Chantratita, N., Beg, S., Stratilo, C. W., Olive, A. J., Soltes, G., Russell, M. L., Limmathurotsakul, D., Norton, R. E., Ni, S. X., Picking, W. D., Jackson, P. J., Stewart, D. I., Tsvetnitsky, V., Picking, W. L., Cherwonogrodzky, J. W., Ketheesan, N., Peacock, S. J., and Wiersma, E. J. (2008). Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents. FEMS Immunol. Med. Microbiol. 52, 78-87.
48. Eichelberg, K., Ginocchio, C. C., and Galan, J. E. (1994). Molecular and functional characterization of the Salmonella typhimurium invasion genes invB and invC: homology of InvC to the F0F1 ATPase family of proteins. J. Bacteriol. 176, 4501-4510.
49. El Solh, A. A., Akinnusi, M. E., Wiener-Kronish, J. P., Lynch, S. V., Pineda, L. A., and Szarpa, K. (2008). Persistent infection with Pseudomonas aerugi-nosa in ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 178,513-519.
50. El Solh, A. A., and Alhajhusain, A. (2009). Update on the treatment of Pseudomonas aeruginosa pneumonia. J. Antimicrob. Chemother. 64, 229-238.
51. Epler, C. R., Dickenson, N. E., Olive, A. J., Picking, W. L., and Picking, W. D. (2009). Liposomes recruit IpaC to the Shigella type III secretion apparatus needle as a final step in secretion induction. Infect. Immun. 77, 2754-2761.
52. Erskine, P. T., Knight, M. J., Ruaux, A., Mikolajek, H., Sang, N. W. F., Withers, J., Gill, R., Wood, S. P., Wood, M., Fox, G. C., and Cooper, J. B. (2006). High resolution structure of BipD: an invasion protein associated with the type III secretion system of Burkholderia pseudomallei. J. Mol. Biol. 363,125-136.
53. Espina, M., Olive, A. J., Kenjale, R., Moore, D. S., Ausar, S. F., Kaminski, R. W., Oaks, E. V., Middaugh, C. R., Picking, W D., and Picking, W L. (2006). IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri. Infect. Immun. 74,4391-4400.
54. Ferracci, F., Schubot, F. D., Waugh, D. S., and Plano, G. V. (2005). Selection and characterization of Yersinia pestis YopN mutants that consti-tutively block Yop secretion. Mol. Microbiol. 57, 970-987.
55. Fields, K. A., Nilles, M. L., Cowan, C., and Straley, S. C. (1999). Virulence role of V antigen of Yersinia pestis at the bacterial surface. Infect. Immun. 67, 5395-5408.
56. Forsberg, A., Viitanen, A. M., Skurnik, M., and Wolf-Watz, H. (1991). The surface-located YopN protein is involved in calcium signal transduc-tion in Yersinia pseudotuberculosis. Mol. Microbiol. 5, 977-986.
57. Frank, D. W (1997). The exoenzyme S regulon of Pseudomonas aeruginosa. Mol. Microbiol. 26, 621-629.
58. Frank, D. W., Nair, G., and Schweizer, H. P. (1994). Construction and characterization of chromosomal inser-tional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus. Infect. Immun. 62, 554-563.
59. Frank, D. W., Vallis, A., Wiener-Kronish, J. P., Roy-Burman, A., Spack, E. G., Mullaney, B. P., Megdoud, M., Marks, J. D., Fritz, R., and Sawa, T. (2002). Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. J. Infect. Dis. 186, 64-73.
60. Frithz-Lindsten, E., Holmstrom, A., Jacobsson, L., Soltani, M., Olsson, J., Rosqvist, R., and Forsberg, A. (1998). Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudo-tuberculosis. Mol. Microbiol. 29, 1155-1165.
61. Galan, J. E., and Collmer, A. (1999). Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284, 1322-1328.
62. Galan, J. E., and Wolf-Watz, H. (2006). Protein delivery into eukaryotic cells by type III secretion machines. Nature 444, 567-573.
63. Garrity-Ryan, L. K., Kim, O. K., Balada-Llasat, J. M., Bartlett, V. J., Verma, A. K., Fisher, M. L., Castillo, C., Song-sungthong, W., Tanaka, S. K., Levy, S. B., Mecsas, J., and Alekshun, M. N. (2010). Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model. Infect. Immun. 78,4683-4690.
64. Gotoh, K., Kodama, T., Hiyoshi, H., Izutsu, K., Park, K. S., Dryselius, R., Akeda, Y., Honda, T., and Iida, T. (2010). Bile acid-induced virulence gene expression of Vibriopara-haemolyticus reveals a novel therapeutic potential for bile acid seques-trants. PLoS ONE 5, e13365. doi: 10.1371/journal.pone.0013365
65. Goure, J., Broz, P., Attree, O., Cor-nelis, G. R., and Attree, I. (2005). Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. J. Infect. Dis. 192, 218-225.
66. Goure, J., Pastor, A., Faudry, E., Chabert, J., Dessen, A., and Attree, I. (2004). The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes. Infect. Immun. 72, 4741-4750.
67. Guex, N., and Peitsch, M. C. (1997). SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Elec-trophoresis 18,2714-2723.
68. Hakansson, S., Schesser, K., Persson, C., Galyov, E. E., Rosqvist, R., Homble, E, and Wolf-Watz, H. (1996). The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J. 15,5812-5823.
69. Hauser, A. R. (2009). The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 7, 654-665.
70. Heurtault, B., Gentine, P., Thomann, J. S., Baehr, C., Frisch, B., and Pons, F. (2009). Design of a liposomal candidate vaccine against Pseudomonas aeruginosa and its evaluation in triggering systemic and lung mucosal immunity. Pharm. Res. 26, 276-285.
71. Hill, J., Leary, S. E., Griffin, K. F., Williamson, E. D., and Titball, R. W. (1997). Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect. Immun. 65, 4476-4482.
72. Holder, I. A., Neely, A. N., and Frank, D. W (2001). PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice. Infect. Immun. 69, 5908-5910.
73. Holmstrom, A., Olsson, J., Cherepanov, P., Maier, E., Nordfelth, R., Petters-son, J., Benz, R., Wolf-Watz, H., and Forsberg, A. (2001). LcrV is a channel size-determining component of the Yop effector translocon of Yersinia. Mol. Microbiol. 39, 620-632.
74. Hueck, C. J. (1998). Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62, 379-433.
75. Imamura, Y., Yanagihara, K., Fukuda, Y., Kaneko, Y., Seki, M., Izumikawa, K., Miyazaki, Y., Hirakata, Y., Sawa, T., Wiener-Kronish, J. P., and Kohno, S. (2007). Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model. Eur. Respir. J. 29, 965-968.
76. Iriarte, M., Sory, M. P., Boland, A., Boyd, A. P., Mills, S. D., Lamber-mont, I., and Cornelis, G. R. (1998). TyeA, a protein involved in control of Yop release and in translocation of Yersinia Yop effectors. EMBOJ. 17, 1907-1918.
77. Johnson, S., Roversi, P., Espina, M., Olive, A., Deane, J. E., Birket, S., Field, T., Picking, W. D., Blocker, A. J., Galyov, E. E., Picking, W L., and Lea, S. M. (2007). Self-chaperoning of the type III secretion system needle tip proteins IpaD and BipD. J. Biol. Chem. 282, 4035-4044.
78. Journet, L., Agrain, C., Broz, P., and Cornelis, G. R. (2003). The needle length of bacterial injectisomes is determined by a molecular ruler. Science 302,1757-1760.
79. Kamei, A., Coutinho-Sledge, Y S., Goldberg, J. B., Priebe, G. P., and Pier, G. B. (2011). Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection. Infect. Immun. 79, 1289-1299.
80. Kang, Y., Lunin, V. V., Skarina, T., Savchenko, A., Schurr, M. J., and Hoang, T. T. (2009). The long-chain fatty acid sensor, PsrA, modulates the expression of rpoS and the type III secretion exsCEBA operon in Pseudomonas aeruginosa. Mol. Microbiol. 73, 120-136.
81. Kenjale, R., Wilson, J., Zenk, S. F., Saurya, S., Picking, W.L., Picking, W. D., and Blocker, A. (2005). The needle component of the type III secre-ton of Shigella regulates the activity of the secretion apparatus. J. Biol. Chem. 280, 42929-42937.
82. Knutton, S., Rosenshine, I., Pallen, M. J., Nisan, I., Neves, B. C., Bain, C., Wolff, C., Dougan, G., and Frankel, G. (1998). A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 17, 2166-2176.
83. La Ragione, R. M., Patel, S., Mad-dison, B., Woodward, M. J., Best, A., Whitelam, G. C., and Gough, K. C. (2006). Recombinant anti-EspA antibodies block Escherichia coli O157:H7-induced attaching and effacing lesions in vitro. Microbes Infect. 8, 426-433.
84. Lara-Tejero M., Galan J.E. Salmonella enterica serovar typhimurium pathogenicity island 1-encoded type III secretion system translocases mediate intimate attachment to nonphagocytic cells. Infect. Immun. 2009. 77: 2635-2642.
85. Lara-Tejero, M., Kato, J., Wagner, S., Liu, X., and Galan, J. E. (2011). A Sorting Platform Determines the Order of Protein Secretion in Bacterial Type III Systems. Science 1188, 1188-1191.
86. Lawton, W. D., Erdman, R. I., and Sur-galla, M. J. (1963). Biosynthesis and purification of V and W antigen in Pasteurella pestis. J. Immunol. 91, 179-184.
87. Leary, S. E., Williamson, E. D., Griffin, K. F., Russell, P., Eley, S. M., and Titball, R. W (1995). Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63,2854-2858.
88. Lee, P. C., Stopford, C. M., Svenson, A. G., and Rietsch, A. (2010). Control of effector export by the P. aeruginosa type III secretion proteins PcrG and PcrV. Mol. Microbiol. 75, 924-941.
89. Lee, V. T., Pukatzki, S., Sato, H., Kikawada, E., Kazimirova, A. A., Huang, J., Li, X., Arm, J. P., Frank, D. W., and Lory, S. (2007). Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU. Infect. Immun. 75, 1089-1098.
90. Lee, V. T., Tam, C., and Schneewind, O. (2000). LcrV, a substrate for Yersinia enterocolitica type III secretion, is required for toxin targeting into the cytosol of HeLa cells. J. Biol. Chem. 275,36869-36875.
91. Luo, Y., Bertero, M. G., Frey, E. A., Pfuet-zner, R. A., Wenk, M. R., Creagh, L., Marcus, S. L., Lim, D., Sicheri, E, Kay, C., Haynes, C., Finlay, B. B., and Strynadka, N. C. (2001). Structural and biochemical characterization of the type III secretion chaper-ones CesT and SigE. Nat. Struct. Biol. 8, 1031-1036.
92. Marenne, M. N., Journet, L., Mota, L. J., and Cornelis, G. R. (2003). Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN. Microb. Pathog. 35, 243-258.
93. Markham, A. P., Barrett, B. S., Esfandi-ary, R., Picking, W L, Picking, W. D., Joshi, S. B., and Middaugh, C. R. (2010). Formulation and immuno-genicity of a potential multivalent type III secretion system-based protein vaccine. J. Pharm. Sci. 99, 4497-4509.
94. Markham, A. P., Jaafar, Z. A., Kemege, K. E., Middaugh, C. R., and Hefty, P. S. (2009). Biophysical characterization of Chlamydia trachomatis CT584 supports its potential role as a type III secretion needle tip protein. Biochemistry 48, 10353-10361.
95. Marteyn, B., West, N. P., Browning, D. E, Cole, J. A., Shaw, J. G., Palm, F., Mounier, J., Prevost, M. C., San-sonetti, P., and Tang, C. M. (2010). Modulation of Shigella virulence in response to available oxygen in vivo. Nature 465, 355-358.
96. Martinez-Argudo, I., and Blocker, A. J. (2010). The Shigella T3SS needle transmits a signal for MxiC release, which controls secretion of effectors. Mol. Microbiol. 78, 1365-1378.
97. Matson, J. S., Durick, K. A., Bradley, D. S., and Nilles, M. L. (2005). Immunization of mice with YscF provides protection from Yersinia pestis infections. BMC Microbiol. 5, 38. doi: 10.1186/1471-2180-5-38
98. Matson, J. S., and Nilles, M. L. (2001). LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis. J. Bacteriol. 183, 5082-5091.
99. McCaw, M. L., Lykken, G. L., Singh, P. K., and Yahr, T. L. (2002). ExsD is a negative regulator of the Pseudomonas aeruginosa type III secretion regu-lon. Mol. Microbiol. 46, 1123-1133.
100. Medhekar, B., Shrivastava, R., Mattoo, S., Gingery, M., and Miller, J. F. (2009). Bordetella Bsp22 forms a filamentous type III secretion system tip complex and is immuno-protective in vitro and in vivo. Mol. Microbiol. 71, 492-504.
101. Menard, R., Sansonetti, P., and Par-sot, C. (1994). The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD. EMBO J. 13,5293-5302.
102. Menard, R., Sansonetti, P. J., and Parsot, C. (1993). Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J. Bacteriol. 175, 5899-5906.
103. Moraes, T. F., Spreter, T., and Strynadka, N.C. (2008). Piecing together the type III injectisome of bacterial pathogens. Curr. Opin. Struct. Biol. 18,258-266.
104. Moriyama, K., Wiener-Kronish, J. P., and Sawa, T. (2009). Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice. Microbiol. Immunol. 53, 587-594.
105. Mota, L. J., and Cornelis, G. R. (2005). The bacterial injection kit: type III secretion systems. Ann. Med. 37, 234-249.
106. Mo tin, V. L., Kutas, S. M., and Brubaker, R. R. (1997). Suppression of mouse skin allograft rejection by protein A-YersiniaeVantigen fusion peptide. Transplantation 63, 1040-1042.
107. Motin, V. L., Nakajima, R., Smirnov, G. B., and Brubaker, R. R. (1994). Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect. Immun. 62, 4192-4201.
108. Mueller, C. A., Broz, P., and Cornelis, G. R. (2008). The type III secretion system tip complex and translocon. Mol. Microbiol. 68, 1085-1095.
109. Mueller, C. A., Broz, P., Muller, S. A., Ringler, P., Erne-Brand, F., Sorg, I., Kuhn, M., Engel, A., and Cornelis, G. R. (2005). The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310, 674-676.
110. Nakajima, R., and Brubaker, R. R. (1993). Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect. Immun. 61,23-31.
111. Nakajima, R., Motin, V L., and Brubaker, R. R. (1995). Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. 63, 3021-3029.
112. Nedialkov, Y. A., Motin, V L., and Brubaker, R. R. (1997). Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect. Immun. 65, 1196-1203.
113. Neely, A. N., Holder, I. A., Wiener-Kronish, J. P., and Sawa, T. (2005). Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge. Burns 31, 153-158.
114. Neyt, C., and Cornelis, G. R. (1999). Insertion of a Yop translocation pore into the macrophage plasma membrane by Yersinia enterocolitica: requirement for translocators YopB and YopD, but not LcrG. Mol. Microbiol. 33,971-981.
115. Nilles, M. L., Fields, K. A., and Stra-ley, S. C. (1998). The V antigen of Yersinia pestis regulates Yop vector-ial targeting as well as Yop secretion through effects on YopB and LcrG. J. Bacteriol. 180,3410-3420.
116. Nilles, M. L., Williams, A. W., Skrzypek, E., and Straley, S. C. (1997). Yersinia pestis LcrV forms a stable complex with LcrG and may have a secretion-related regulatory role in the low-Ca2+ response. J. Bacteriol. 179,1307-1316.
117. Olive, A. J., Kenjale, R., Espina, M., Moore, D. S., Picking, W L, and Picking, W. D. (2007). Bile salts stimulate recruitment of IpaB to the Shigella flexneri surface, where it colocalizes with IpaD at the tip of the type III secretion needle. Infect. Immun. 75, 2626-2629.
118. Overheim, K. A., Depaolo, R. W., DeBord, K. L., Morrin, E. M., Anderson, D. M., Green, N. M., Brubaker, R. R., Jabri, B., and Schneewind, O. (2005). LcrV plague vaccine with altered immunomodu-latory properties. Infect. Immun. 73, 5152-5159.
119. Parsot, C. (2009). Shigella type III secretion effectors: how, where, when, for what purposes? Current Opinion in Microbiology 12, 110-116.
120. Persson, C., Nordfelth, R., Holmstrom, A., Hakansson, S., Rosqvist, R., and Wolf-Watz, H. (1995). Cell-surface-bound Yersinia translocate the protein tyrosine phosphatase YopH by a polarized mechanism into the target cell. Mol. Microbiol. 18, 135-150.
121. Pettersson, J., Holmstrom, A., Hill, J., Leary, S., Frithz-Lindsten, E., Euler-Matell, A., Carlsson, E., Titball, R., Forsberg, A., and Wolf-Watz, H. (1999). The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol. Microbiol. 32,961-976.
122. Pettersson, J., Nordfelth, R., Dubin-ina, E., Bergman, T., Gustafsson, M., Magnusson, K. E., and Wolf-Watz, H. (1996). Modulation of virulence factor expression by pathogen target cell contact. Science 273, 1231-1233.
123. Picking, W. L., Nishioka, H., Hearn, P. D., Baxter, M. A., Harrington, A. T., Blocker, A., and Picking, W. D. (2005). IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes. Infect. Immun. 73, 1432-1440.
124. Powell, B. S., Andrews, G. P., Enama, J. T., Jendrek, S., Bolt, C., Wor-sham, P., Pullen, J. K., Ribot, W., Hines, H., Smith, L., Heath, D. G., and Adamovicz, J. J. (2005). Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol. Prog. 21, 1490-1510.
125. Price, S. B., Cowan, C., Perry, R. D., and Straley, S. C. (1991). The Yersinia pestis V antigen is a regulatory protein necessary for Ca2+ -dependent growth and maximal expression of low-Ca2+ response virulence genes. J. Bacteriol. 173,2649-2657.
126. Quenee, L. E., Berube, B. J., Segal, J., Elli, D., Ciletti, N. A., Anderson, D., and Schneewind, O. (2010). Amino acid residues 196-225 of LcrV represent a plague protective epitope. Vaccine 28, 1870-1876.
127. Quenee, L. E., and Schneewind, O. (2009). Plague vaccines and the molecular basis of immunity against Yersinia pestis. Hum. Vaccin. 5, 817-823.
128. Rathinavelan, T., Tang, C., and De Guzman, R. N. (2011). Characterization of the interaction between the Salmonella type III secretion system tip protein SipD and the needle protein PrgI by paramagnetic relaxation enhancement. J. Biol. Chem. 286, 4922-4930.
129. Rello, J., Ausina, V., Ricart, M., Castella, J., and Prats, G. (1993). Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 104, 1230-1235.
130. Rietsch, A., and Mekalanos, J. J. (2006). Metabolic regulation of type III secretion gene expression in Pseudomonas aeruginosa. Mol. Microbiol. 59, 807-820.
131. Rietsch, A., Vallet-Gely, I., Dove, S. L., and Mekalanos, J. J. (2005). ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U.S.A. 102,8006-8011.
132. Rietsch, A., Wolfgang, M. C., and Mekalanos, J. J. (2004). Effect of metabolic imbalance on expression of type III secretion genes in Pseudomonas aeruginosa. Infect. Immun. 72, 1383-1390.
133. Rimpilainen, M., Forsberg, A., and Wolf-Watz, H. (1992). A novel protein, LcrQ, involved in the low-calcium response of Yersinia pseudo-tuberculosis shows extensive homol-ogy to YopH. J. Bacteriol. 174, 3355-3363.
134. Riordan, K. E., and Schneewind, O. (2008). YscU cleavage and the assembly of Yersinia type III secretion machine complexes. Mol. Microbiol. 68,1485-1501.
135. Rosqvist, R., Magnusson, K. E., and Wolf-Watz, H. (1994). Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBOJ. 13,964-972.
136. Roy, D., Liston, D. R., Idone, V. J., Di, A., Nelson, D. J., Pujol, C., Bliska, J. B., Chakrabarti, S., and Andrews, N. W (2004). A process for controlling intracellular bacterial infections induced by membrane injury. Science 304,1515-1518.
137. Roy-Burman, A., Savel, R. H., Racine, S., Swanson, B. L., Revadigar, N. S., Fujimoto, J., Sawa, T., Frank, D. W., and Wiener-Kronish, J. P. (2001). Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183, 1767-1774.
138. Sarker, M. R., Neyt, C., Stainier, I., and Cornelis, G. R. (1998). The Yersinia Yop virulon: LcrV is required for extrusion of the translo-cators YopB and YopD. J. Bacteriol. 180,1207-1214.
139. Sato, H., Hunt, M. L., Weiner, J. J., Hansen, A. T., and Frank, D. W. (2011). Modified needle-tip PcrV proteins reveal distinct phenotypes relevant to the control of type III secretion and intoxication by Pseudomonas aeruginosa. PLoS ONE 6,e18356.
140. Sawa, T., Yahr, T. L., Ohara, M., Kura-hashi, K., Gropper, M. A., Wiener-Kronish, J. P., and Frank, D. W. (1999). Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat. Med. 5, 392-398.
141. Schoehn, G., Di Guilmi, A. M., Lemaire, D., Attree, I., Weissenhorn, W., and Dessen, A. (2003). Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas. EMBO J. 22, 4957-4967.
142. Schroeder, G. N., and Hilbi, H. (2008). Molecular pathogenesis of Shigella spp.: Controlling host cell signaling, invasion, and death by type III secretion. Clin. Microbiol. Rev. 21, 134-156.
143. Schubot, F. D., Jackson, M. W., Penrose, K. J., Cherry, S., Tropea, J. E., Plano, G. V., and Waugh, D. S. (2005). Three-dimensional structure of a macromolecular assembly that regulates type III secretion in Yersinia pestis. I Mol. Biol. 346, 1147-1161.
144. Schuller, S., and Phillips, A. D. (2010). Microaerobic conditions enhance type III secretion and adherence of enterohaemorrhagic Escherichia coli to polarized human intestinal epithelial cells. Environ. Microbiol. 12,2426-2435.
145. Shime, N., Sawa, T., Fujimoto, J., Faure, K., Allmond, L. R., Karaca, T., Swanson, B. L., Spack, E. G., and Wiener-Kronish, J. P. (2001). Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa. J. Immunol. 167, 5880-5886.
146. Sing, A., Reithmeier-Rost, D., Granfors, K., Hill, J., Roggenkamp, A., and Heesemann, J. (2005). A hypervari-able N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc. Natl. Acad. Sci. U.S.A. 102, 16049-16054.
147. Sing, A., Roggenkamp, A., Geiger, A. M., and Heesemann, J. (2002a). Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 168, 1315-1321.
148. Sing, A., Rost, D., Tvardovskaia, N., Roggenkamp, A., Wiedemann, A., Kirschning, C. J., Aepfelbacher, M., and Heesemann, J. (2002b). Yersinia V-antigen exploits toll-like receptor 2 and CD 14 for interleukin 10-mediated immunosuppression. J. Exp.Med. 196,1017-1024.
149. 2+ response, and virulence of Yersinia pestis. J. Bacteriol. 177,2530-2542.
150. Sorg, I., Wagner, S., Amstutz, M., Muller, S. A., Broz, P., Lussi, Y., Engel, A., and Cornelis, G. R. (2007). YscU recognizes translocators as export substrates of the Yersinia injectisome. EMBOJ. 26, 3015-3024.
151. Sory, M. P., and Cornelis, G. R. (1994). Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol. Microbiol. 14, 583-594.
152. Stebbins, C. E., and Galan, J. E. (2003). Priming virulence factors for delivery into the host. Nat. Rev. Mol. Cell Biol. 4, 738-743.
153. Stensrud, K. F., Adam, P. R., La Mar, C. D., Olive, A. J., Lushington, G. H., Sudharsan, R., Shelton, N. L., Givens, R. S., Picking, W L., and Picking, W. D. (2008). Deoxycholate interacts with IpaD of Shigella flexneri in inducing the recruitment of IpaB to the type III secretion apparatus needle tip. J. Biol. Chem. 283, 18646-18654.
154. Sundin, C., Thelaus, J., Broms, J. E., and Forsberg, A. (2004). Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN. Microb. Pathog. 37,313-322.
155. Torruellas, J., Jackson, M. W., Pennock, J. W., and Plano, G. V (2005). The Yersinia pestis type III secretion needle plays a role in the regulation of Yop secretion. Mol. Microbiol. 57, 1719-1733.
156. Troisfontaines, P., and Cornelis, G. R. (2005). Type III secretion: more systems than you think. Physiology 20, 326-339.
157. Une, T., and Brubaker, R. R. (1984). Roles of V antigen in promoting virulence and immunity in Yersiniae. J. Immunol. 133,2226-2230.
158. Urbanowski, M. L., Brutinel, E. D., and Yahr, T. L. (2007). Translocation of ExsE into Chinese hamster ovary cells is required for transcriptional induction of the Pseudomonas aeruginosa type III secretion system. Infect. Immun. 75, 4432-4439.
159. Urbanowski, M. L., Lykken, G. L., and Yahr, T. L. (2005). A secreted regulatory protein couples transcription to the secretory activity of the Pseudomonas aeruginosa type III secretion system. Proc. Natl. Acad. Sci. U.S.A. 102, 9930-9935.
160. Urbanowski, M. L., and Yahr, T. L. (2008). Limiting too much of a good thing: a negative feedback mechanism prevents unregulated translocation of type III effector proteins. J. Bacteriol. 190, 2643-2644.
161. Vallis, A. J., Finck-Barbancon, V., Yahr, T. L., and Frank, D. W. (1999a). Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect. Immun. 67, 2040-2044.
162. Vallis, A. J., Yahr, T. L., Barbieri, J. T., and Frank, D. W. (1999b). Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions. Infect. Immun. 67,914-920.
163. Van Blarcom, T. J., Sofer-Podesta, C., Ang, J., Boyer, J. L., Crystal, R. G., and Georgiou, G. (2010). Affinity maturation of an anti-V antigen IgG expressed in situ through adenovirus gene delivery confers enhanced protection against Yersinia pestis challenge. Gene Ther. 17, 913-921.
164. van der Goot, F. G., Tran, v. N., Allaoui, A., Sansonetti, P., and Lafont, E. (2004). Rafts can trigger contact-mediated secretion of bacterial effectors via a lipid-based mechanism. J. Biol. Chem. 279, 47792-47798.
165. Veenendaal, A. K., Hodgkinson, J. L., Schwarzer, L., Stabat, D., Zenk, S. F., and Blocker, A. J. (2007). The type III secretion system needle tip complex mediates host cell sensing and translocon insertion. Mol. Microbiol. 63,1719-1730.
166. Veenendaal, A. K., Sundin, C., and Blocker, A. J. (2009).Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton. J. Bacteriol. 191, 563-570.
167. Vernazza, C., Lingard, B., Flick-Smith, H. C., Baillie, L. W., Hill, J., and Atkins, H. S. (2009). Small protective fragments of the Yersinia pestis V antigen. Vaccine 27,2775-2780.
168. Viboud, G. I., and Bliska, J. B. (2001). A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes. EMBO J. 20, 5373-5382.
169. Wang, J., Zhang, Y., Lu, C., Lei, L., Yu, P., and Zhong, G. (2010a). A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J. Immunol. 185,1670-1680.
170. Wang, Y., Nordhues, B. A., Zhong, D., and De Guzman, R. N. (2010b). NMR characterization of the interaction of the Salmonella type III secretion system protein SipD and bile salts. Biochemistry 49, 4220-4226.
171. Wangdi, T., Mijares, L. A., and Kazmierczak, B. I. (2010). In vivo discrimination of type 3 secretion system-positive and -negative Pseudomonas aerugi-nosa via a caspase-1-dependent pathway. Infect. Immun. 78, 4744-4753.
172. Wilharm, G., Lehmann, V., Krauss, K., Lehnert, B., Richter, S., Ruckdeschel, K., Heesemann, J., and Trulzsch, K. (2004). Yersinia enterocolitica type III secretion depends on the proton motive force but not on the flagel-lar motor components MotA and MotB. Infect. Immun. 72,4004-4009.
173. Williamson, E. D., Flick-Smith, H. C., Lebutt, C., Rowland, C. A., Jones, S. M., Waters, E. L., Gwyther, R. J., Miller, J., Packer, P. J., and Irving, M. (2005). Human immune response to a plague vaccine comprising recom-binant F1 and V antigens. Infect. Immun. 73, 3598-3608.
174. Wulff-Strobel, C. R., Williams, A. W., and Straley, S. C. (2002). LcrQ and SycH function together at the Ysc type III secretion system in Yersinia pestis to impose a hierarchy of secretion. Mol. Microbiol. 43, 411-423.
175. Yahr, T. L., Mende-Mueller, L. M., Friese, M.B., and Frank, D.W (1997). Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon. J. Bacteriol. 179,7165-7168.
176. Yahr, T. L., and Wolfgang, M. C. (2006). Transcriptional regulation of the Pseudomonas aeruginosa type III secretion system. Mol. Microbiol. 62, 631-640.
177. Yip, C. K., Finlay, B. B., and Strynadka, N. C. J. (2005). Structural characterization of a type III secretion system filament protein in complex with its chaperone. Nat. Struct. Mol. Biol. 12, 75-81.
178. Yogurtcu, O. N., Wolgemuth, C. W., and Sun, S. X. (2010). Mechanical response and conformational amplification in alpha-helical coiled coils. Biophys. J. 99, 3895-3904.
179. Yu, S., Gu, J., Wang, H. G., Wang, Q. X., Luo, P., Wu, C., Zhang, W J., Guo, G., Tong, W D., Zou, Q. M., and Mao, X. H. (2011). Identification of a novel linear epitope on EspA from enterohemorrhagic E. coli using a neutralizing and protective monoclonal antibody. Clin. Immunol. 138, 77-84.
180. Yu, X. J., McGourty, K., Liu, M., Unsworth, K. E., and Holden, D. W (2010). pH sensing by intracellular Salmonella induces effector translocation. Science 328, 1040-1043.
181. Zhou, X., Konkel, M. E., and Call, D. R. (2010). Vp1659 is a Vibrio parahaemolyticus type III secretion system 1 protein that contributes to translocation of effector proteins needed to induce cytolysis, autophagy, and disruption of actin structure in HeLa cells. J. Bacteriol. 192,3491-3502.